In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab

Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent

(2015) N. F. Dybdal-Hargreaves et al.   CLINICAL CANCER RESEARCH

Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy

(2014) Jon Etxano et al.   ACTA RADIOLOGICA

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

(2014) Chris Twelves et al.   BREAST CANCER RESEARCH AND TREATMENT

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states

(2014) T Yoshida et al.   BRITISH JOURNAL OF CANCER

Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy

(2014) Noriko Nakamiya et al.   CANCER SCIENCE

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models

(2014) Yasuhiro Funahashi et al.   CANCER SCIENCE

Bevacizumab: A Review of Its Use in Advanced Cancer

(2014) Gillian M. Keating   DRUGS

TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis

(2014) D. R. Principe et al.   JNCI-Journal of the National Cancer Institute

Optical Imaging for Monitoring Tumor Oxygenation Response after Initiation of Single-Agent Bevacizumab followed by Cytotoxic Chemotherapy in Breast Cancer Patients

(2014) Shigeto Ueda et al.   PLoS One

Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells

(2014) Zoltán Dezső et al.   PLoS One

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast

(2013) Shigeto Ueda et al.   BMC CANCER

Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs

(2012) Astrid A.M. Van der Veldt et al.   CANCER CELL

Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression

(2011) Michael K. Wendt et al.   CELL AND TISSUE RESEARCH

Role of TGF-β and the Tumor Microenvironment During Mammary Tumorigenesis

(2011) MOLLY A. TAYLOR et al.   GENE EXPRESSION

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy

(2011) A. E. Cerussi et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment

(2011) D. Roblyer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Eribulin Binds at Microtubule Ends to a Single Site on Tubulin To Suppress Dynamic Instability

(2009) Jennifer A. Smith et al.   BIOCHEMISTRY